Clinical Trial Update: A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for NSC001 assessing safety, tolerability, and exploratory efficacy in mild-to-moderate Alzheimer's disease; the study is in Phase 1/Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NSC001 (NSC001)

Snippet

Sponsor: NSC-Therapeutics | Conditions: Alzheimer Disease | Phase 1, Phase 2 | Status: RECRUITING